Clinical Study

Lipid and Protein Oxidation in Newborn Infants after Lutein Administration

Table 2

TH (total hydroperoxide, mmol/H2O2), AOPP (advanced oxidative protein products, micro-mol/L), and BAP (biological antioxidant potential, micro-mol/L) plasma levels in control and test groups.

Control group ( )Test group ( )
Cord blood48 hrs of lifeCord blood48 hrs of life

TH median 
(q25–q75)
127.6 (99.1–160.6)169.3 (132.5–263.5)150.9 (112.5–185.7)179.0 (140.5–244.0)
TH mean (SD)138.03 (±52.50)191.43 (±82.32)156.75 (±64.0)195.0 (±77.54)
AOPP median 
(q25–q75)
15.07 (12.7–55.42)35.72 (24.64–68.82)39.27 (14.54–56.14)70.87 (41.34–81.48)
AOPP mean (SD)27.52 (±20.58)48.40 (±33.68)36.10 (±20.73)64.84 (±31.23)
BAP median 
(q25–q75)
3359.6 (2808.6–3966.7)3287.2 (2660.3–3510.6)2289.2 (2112.2–2485.3)2717.1 (2528.7–2905.8)
BAP mean (SD)3353.7 (±990.5)3273.2 (±937.9)2361 (±466)2699 (±284.2)